6-(4-Methoxyphenyl)pyridazin-3(2H)-one

Catalog No. :
ACWDGP760
CAS No. :
2166-33-8
Molecular Formula :
C11H10N2O2
Molecular Weight :
202.21

IUPAC Name:6-(4-Methoxyphenyl)pyridazin-3(2H)-one

6-(4-Methoxyphenyl)pyridazin-3(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$64.00Login to see priceInquiryInquiry
250mg95%$117.00Login to see priceInquiryInquiry
1g95%$217.00Login to see priceInquiryInquiry
5g95%$525.00Login to see priceInquiryInquiry
10g95%$826.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(4-Methoxyphenyl)pyridazin-3(2H)-one
IUPAC Name6-(4-Methoxyphenyl)pyridazin-3(2H)-one
MDL No.MFCD02679807
Molecular FormulaC11H10N2O2
Molecular Weight202.21
SMILESO=C1C=CC(C2=CC=C(OC)C=C2)=NN1
InChI KeyHEKMSRLHSLEVMF-UHFFFAOYSA-N
Synonymp-Anisylpyridazone;6-(4-methoxyphenyl)pyridazin-3(2H)-one;6-(4-Methoxyphenyl)-3(2H)-pyridazinone;6-(p-Methoxyphenyl)-3(2H)-pyridazinone;3-Hydroxy-6-(4-methoxyphenyl)pyridazine;6-(4-methoxyphenyl)-2,3-dihydropyridazin-3-one;6-(4-Methoxyphenyl)-2H-pyridazin-3-one;3(2H)-Pyridazinone, 6-(4-methoxyphenyl)-
CAS No.2166-33-8

Synthetic Route by SureRoute

1. ACWDGP760 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACWDGP760 route product structure diagram
    ACWDGP7602166-33-8
Inquiry

2. ACWDGP760 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFPSA972 route compound structure diagram
    ACFPSA9725720-07-0 In Stock
  2. Plus
  3. ACYMQN926 route compound structure diagram
    ACYMQN92651355-94-3 In Stock
  4. Then
  5. ACWDGP760 route product structure diagram
    ACWDGP7602166-33-8
Inquiry

Comments (0)